
Lawrence F. Eichenfield MD
Pediatric Dermatology
Professor of Dermatology and Pediatrics, UCSD
Join to view full profile
3030 Childrens WaySan Diego, CA 92123
Phone+1 858-966-6795
Dr. Eichenfield is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Pennsylvania Health SystemResidency, Dermatology, 1988 - 1991
Children's Hospital of PhiladelphiaResidency, Pediatrics, 1984 - 1987
Icahn School of Medicine at Mount SinaiClass of 1984
Certifications & Licensure
CA State Medical License 1990 - 2027
PA State Medical License 1986 - 1992
American Board of Dermatology Dermatology
American Board of Dermatology Pediatric Dermatology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2004-2014
- Top Doctors:San Diego Area Castle Connolly, 2013
- Top Doctors:Southern California Castle Connolly, 2012
Clinical Trials
Publications & Presentations
PubMed
- Long-term treatment of atopic dermatitis with roflumilast cream 0.15% in patients aged 6 years or older (INTEGUMENT-OLE clinical study): a plain language summary.Eric Simpson, Lawrence F Eichenfield, Kim A Papp, Seth B Forman, Adelaide A Hebert
The Journal of Dermatological Treatment. 2026-12-01 - 1 citationsImprovements in clinical and patient-reported outcomes and durability of response with the targeted oral peptide icotrokinra in adolescents with moderate-to-severe pla...Jennifer Soung, Mark G Lebwohl, Adelaide Hebert, Andrew E Pink, Yuling Shi
Journal of the American Academy of Dermatology. 2026-10-01 - Development of a Conceptual Disease Model of Atopic Dermatitis Using Data from the Phase 3 ARCADIA 1 Trial.Jonathan I Silverberg, Patrick Daniele, Danielle Rodriguez, Sarah Mulnick, Gil Yosipovitch
Dermatology and Therapy. 2026-09-22
Journal Articles
- Efficacy and Safety of Baricitinib Combined with Topical Corticosteroids for Treatment of Moderate to Severe Atopic DermatitisLawrence F Eichenfield, Eric L Simpson, JAMA Dermatology
- Safety and Efficacy of VP-102, a Proprietary, Drug-Device Combination Product Containing Cantharidin, 0.7% (w/v), in Children and Adults with Molluscum ContagiosumLawrence F Eichenfield, Wendy Mcfalda, Pearl Kwong, JAMA Dermatology
- Atopic Dermatitis: New DevelopmentsLawrence F Eichenfield, Allison M Han, ScienceDirect
Press Mentions
FDA Accepts sNDA for Roflumilast Cream 0.05% in Infants with ADJuly 8th, 2026
FDA Accepts Supplemental New Drug Application for Arcutis’ ZORYVE® (Roflumilast) Cream 0.05% for the Treatment of Mild to Moderate Atopic Dermatitis in Infants Down to 3 MonthsJuly 8th, 2026
Zoryve Cream 0.05% Approved for Atopic Dermatitis in 2- to 5-Year-OldsOctober 10th, 2025
Professional Memberships
- Fellow
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: